Heavy menstrual bleeding, obstetric fistula and female genital schistosomiasis often go undiagnosed and untreated across Africa, according to an opinion piece published on AllAfrica. The article argues that effective treatments exist, but health systems often fail to organise, equip and finance them.

The piece says heavy menstrual bleeding affects 10 to 30 percent of women of reproductive age in Africa. It estimates that up to 56 million women and girls in sub-Saharan Africa may have female genital schistosomiasis. It also cites roughly 500,000 women and girls worldwide living with obstetric fistula, with the greatest burden in sub-Saharan Africa and Asia.

The author attributes the gaps to national health priorities, financing decisions and separate programmes. Female genital schistosomiasis care, for example, often falls between neglected tropical disease programmes and sexual and reproductive health services. The article cites efforts in Kenya to integrate its recognition and treatment into existing reproductive health services.

The article calls on governments to name these conditions as priorities in national health policies and essential service packages. It also urges investment in provider training, diagnostics, medicines and referral systems, and says accountability should track whether women receive timely diagnoses and treatment. It notes that official development assistance declined sharply in 2025. It cites McKinsey Health Institute and World Economic Forum research suggesting that closing the broader women's health gap could add up to US$1 trillion annually to global GDP by 2040.